Lichen planus
Overview
The 6 P's are the core exam target for lichen planus.
•Pruritic - intense itch driven by inflammatory cytokines
•Polygonal - irregular, many-sided shape
•Planar (flat-topped) - band-like infiltrate pressing against epidermis
•Purple/violaceous - dense lymphocytic infiltrate and vascular dilatation
•Papules (or plaques) - solid raised lesions
•Pattern - Wickham's striae: white lacy lines on the surface caused by focal hypergranulosis
•Distribution - flexor aspects of wrists and ankles, lower back, palms, soles, genitalia
•Koebner phenomenon - new lesions appear at sites of skin trauma (scratch, scar, venepuncture)
•Oral involvement (~50%) - white lacy reticular pattern on buccal mucosa; cannot be wiped off (distinguishes from oral candidiasis)
•Other variants - lichen planopilaris (scarring alopecia), nail involvement (longitudinal ridging, pterygium unguis), erosive genital LP
Investigations
•Lichen planus is primarily a clinical diagnosis
•Skin biopsy (punch) - saw-tooth epidermal hyperplasia, hypergranulosis, vacuolar degeneration of basal layer, dense band-like lymphocytic infiltrate at dermo-epidermal junction, Civatte bodies
•Hepatitis C serology (HCV antibody) - strongest systemic association; consider LFTs
•Patch testing - if allergic contact dermatitis (e.g. dental amalgam) suspected in oral LP
Management
•If a causative drug is identified (thiazide diuretics, antimalarials, NSAIDs, ACE inhibitors, gold salts), stop it first
•Avoid skin trauma (prevents Koebnerisation); for oral LP avoid alcohol and smoking (SCC risk)
•Symptomatic itch - chlorphenamine (sedating antihistamine), emollients
🥇 First-line
•clobetasol propionate (potent topical corticosteroid) - reduces inflammation; steroid-impregnated tape for localised lesions
•First-line (steroid-sparing / facial, genital, oral): tacrolimus ointment or pimecrolimus cream (calcineurin inhibitors)
•First-line (oral LP): ciclosporin mouthwash or topical steroid rinses
🥈 Second-line
•prednisolone oral (1-3 month course) for widespread/severe disease; hydroxychloroquine for chronic/relapsing disease (requires baseline eye test); acitretin for hypertrophic LP (teratogenic - pregnancy prevention required)
🥉 Third-line
•methotrexate or azathioprine for refractory disease (monitor FBC, LFTs); UVB phototherapy for extensive lower limb LP
Complications
•Squamous cell carcinoma - most important complication; ~1% lifetime risk in oral LP; biopsy any suspicious lesion; regular follow-up essential
•Scarring alopecia - lichen planopilaris; irreversible once established
•Nail destruction - pterygium unguis can cause permanent nail loss
Prognosis
•Cutaneous LP is often self-limiting - resolves within 1-2 years
•Oral and genital forms are more chronic, prone to relapse, and persist for many years
•Post-inflammatory hyperpigmentation is common after resolution, particularly in darker skin types